Executive Brief: Competitive Landscape and Strategic Developments in the Middle EAST Creutzfeldt Jakob Disease Market
The Middle EAST Creutzfeldt Jakob Disease Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.30 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing incidence of neurodegenerative diseases, heightened awareness of Creutzfeldt Jakob Disease (CJD), and advancements in diagnostic technologies. The...
0 Commenti 0 condivisioni 55 Views 0 Anteprima